Diabetes & CV Disease
Sort by:
AdventHealth
FLOW: The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist
FEATURING
Richard Pratley
- 919 views
- September 17, 2024
- 9
Omnipod®
Clinical Perspectives on Insulin-Requiring Patients with Type 2 Diabetes
FEATURING
Michael Heile
- 330 views
- February 24, 2022
- 2
AHA 2022 Conference Coverage
AHA 2022: GDMT for HFpEF - What Do We and Don't We Know?
FEATURING
Marat Fudim
- 1,420 views
- November 30, 2022
- 11
Houston Methodist DeBakey Heart and Vascular Center
What Are the Key Components of Primary CVD Prevention from ACC/AHA Guidelines?
FEATURING
Salim Virani
- 1,877 views
- November 25, 2020
- 11
EADV 2023 Insights
EADV 2023 Insights: Insulin Resistance in Acanthosis Nigricans
FEATURING
Steven Feldman
- 242 views
- October 25, 2023
- 3
Baylor College of Medicine
Anesthesia and GLP-1R Agonists
FEATURING
Wasif M. Abidi
- 784 views
- June 4, 2024
- 8
MUSC Cardiology
Where Lie the Keys to Treatment of Type 2 Diabetes Mellitus? Finding the Perfect Fit in Comprehensive Diabetes Treatment
FEATURING
Kathie Hermayer
- 943 views
- March 28, 2024
- 9
UChicago Medicine
The Insulin Cost Scandal: Why Does a Century Old Medicine Still Cost So Much?
FEATURING
Kasia Lipska
- 1,802 views
- June 2, 2022
- 10
Practical Ways to Achieve Targets in Diabetes Care
Pitfalls of A1c
FEATURING
Grazia Aleppo
- 1,797 views
- July 26, 2023
- 11
Canadian Collaborative Research Network
Chronic Kidney Disease: New Treatments to Improve Outcomes
FEATURING
Louise Moist
- 1,557 views
- July 26, 2023
- 11
Omnipod®
ADA/AACE Guidelines for T2DM Pump Therapy, Medicare Coverage and New Clinical Data on the Omnipod DASH® System (2/4)
FEATURING
Diana Isaacs
- 158 views
- February 17, 2022
Scripps Health
Chronic Kidney Disease and Advanced Hypertension Management
FEATURING
Christian Mende
- 244 views
- July 3, 2024
- 3
HeartFlow
Can obese patients benefit from the Coronary CTA pathway to diagnose Coronary Artery Disease?
FEATURING
Maros Ferencik
- 1,158 views
- September 6, 2024
- 8
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,155 views
- December 3, 2017
- 8
Piedmont Heart Institute Napa Valley Cardiology Conference
Diabetes and Coronary Artery Disease: How do We Risk Stratify?
FEATURING
Robert Hendel
- 435 views
- November 15, 2019
- 5
KDIGO
SGLT2 Inhibitors and GLP-1 Receptor Agonists: Different Classes, Different Modes of Kidney Protection
FEATURING
Hiddo Lambers Heerspink
- 544 views
- January 24, 2022
- 6
California Medical Association
New Weight Loss Medications: Panacea or Pandora's Box?
FEATURING
Carolyn Jasik
- 966 views
- April 1, 2024
- 9
Johns Hopkins Infectious Disease
Diabetic Foot Ulcer-Related Infection Diagnosis for the Primary Care Practitioner
FEATURING
Marcos Coutinho Schechter
- 666 views
- April 15, 2024
- 7
ERA 2023 Insights
ERA 2023 Insights: Implementation of KDIGO Guidelines for the European Context
FEATURING
Frederik Persson
- 339 views
- August 4, 2023
- 4
